表紙:にきび治療薬の世界市場:規模・現状・予測 (2022年~2028年)
市場調査レポート
商品コード
1073204

にきび治療薬の世界市場:規模・現状・予測 (2022年~2028年)

Global Acne Medicine Market Size, Status and Forecast 2022-2028

出版日: | 発行: QYResearch | ページ情報: 英文 122 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=128.51円
にきび治療薬の世界市場:規模・現状・予測 (2022年~2028年)
出版日: 2022年05月07日
発行: QYResearch
ページ情報: 英文 122 Pages
納期: 2~3営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のにきび治療薬の市場規模は、2021年には34億9,100万米ドル、2028年までに44億2,800万米ドルに達する見通しです。

また、2022年から2028年の間に3.43%のCAGRで成長すると予測されています。

当レポートでは、世界のにきび治療薬の市場について分析し、種類別・用途別・地域別 (国別) の市場動向の見通し (2017年~2028年)、主要企業のプロファイルなどについて調査しております。

目次

第1章 調査概要

  • 調査範囲
  • 種類別の市場分析
    • 市場規模・成長率:種類別 (2017年・2021年・2028年)
    • OTC (市販薬)
    • 処方薬
  • 用途別の市場
    • 市場シェア:用途別 (2017年・2021年・2028年)
    • 局所薬
    • 経口薬
  • 分析対象
  • 分析期間

第2章 世界の成長動向

  • 世界のにきび治療薬市場の展望 (2017年~2028年)
  • にきび治療薬の成長動向:地域別
  • にきび治療薬業界の力学

第3章 主要企業別の競合情勢

  • 主要にきび治療薬企業の収益
  • 市場シェア:企業の種類別 (ティア1、ティア2、ティア3)
  • 分析対象企業:にきび治療薬の収益別のランキング
  • 世界のにきび治療薬市場の集中度
  • にきび治療薬の主要企業:本社・提供エリア
  • にきび治療薬の主要企業:製品・ソリューション・サービス
  • にきび治療薬企業の創立時期
  • 企業合併・買収 (M&A)、拡張計画

第4章 にきび治療薬:種類別の内訳データ

  • 過去の市場規模:種類別 (2017年~2022年)
  • 市場規模の予測:種類別 (2023年~2028年)

第5章 にきび治療薬:用途別の内訳データ

  • 過去の市場規模:用途別 (2017年~2022年)
  • 市場規模の予測:用途別 (2023年~2028年)

第6章 北米

  • 北米のにきび治療薬の市場規模 (2017年~2028年)
  • にきび治療薬の市場規模:種類別
  • にきび治療薬の市場規模:用途別
  • にきび治療薬の市場規模:国別
    • 米国
    • カナダ
    • メキシコ

第7章 欧州

  • 欧州のにきび治療薬の市場規模 (2017年~2028年)
  • にきび治療薬の市場規模:種類別
  • にきび治療薬の市場規模:用途別
  • にきび治療薬の市場規模:国別
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋のにきび治療薬の市場規模 (2017年~2028年)
  • にきび治療薬の市場規模:種類別
  • にきび治療薬の市場規模:用途別
  • にきび治療薬の市場規模:地域別
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 南米

  • 南米のにきび治療薬の市場規模 (2017年~2028年)
  • にきび治療薬の市場規模:種類別
  • にきび治療薬の市場規模:用途別
  • にきび治療薬の市場規模:国別
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカのにきび治療薬の市場規模 (2017年~2028年)
  • にきび治療薬の市場規模:種類別
  • にきび治療薬の市場規模:用途別
  • にきび治療薬の市場規模:国別
    • 中東
    • アフリカ

第11章 主要企業のプロファイル

  • Galderma
  • Bausch Health
  • Teva
  • GlaxoSmithKline
  • Viatris(Mylan)
  • Almirall
  • Sun Pharma
  • Mayne Pharma
  • Lion
  • HUAPONT
  • Sine Pharma

第12章 アナリストの見解/結論

第13章 付録

図表

LIST OF TABLES

  • Table 1. Global Acne Medicine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
  • Table 2. Global Acne Medicine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
  • Table 3. Global Acne Medicine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 4. Global Acne Medicine Market Size by Region (2017-2022) & (US$ Million)
  • Table 5. Global Acne Medicine Market Share by Region (2017-2022)
  • Table 6. Global Acne Medicine Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 7. Global Acne Medicine Market Share by Region (2023-2028)
  • Table 8. Acne Medicine Market Trends
  • Table 9. Acne Medicine Market Drivers
  • Table 10. Acne Medicine Market Restraints
  • Table 11. Acne Medicine Market Growth Strategy
  • Table 12. Global Acne Medicine Revenue by Players (2020-2022) & (US$ Million)
  • Table 13. Global Acne Medicine Market Share by Players (2020-2022)
  • Table 14. Global Top Acne Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acne Medicine as of 2021)
  • Table 15. Ranking of Global Top Acne Medicine Companies by Revenue (US$ Million) in 2021
  • Table 16. Global 5 Largest Players Market Share by Acne Medicine Revenue (CR5 and HHI) & (2020-2022)
  • Table 17. Key Players Headquarters and Area Served
  • Table 18. Key Players Acne Medicine Product Solution and Service
  • Table 19. Founded Date of Acne Medicine Players
  • Table 20. Mergers & Acquisitions, Expansion Plans
  • Table 21. Global Acne Medicine Market Size by Type (2017-2022) & (US$ Million)
  • Table 22. Global Acne Medicine Revenue Market Share by Type (2017-2022)
  • Table 23. Global Acne Medicine Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 24. Global Acne Medicine Revenue Market Share by Type (2023-2028)
  • Table 25. Global Acne Medicine Market Size by Application (2017-2022) & (US$ Million)
  • Table 26. Global Acne Medicine Revenue Market Share by Application (2017-2022)
  • Table 27. Global Acne Medicine Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 28. Global Acne Medicine Revenue Market Share by Application (2023-2028)
  • Table 29. North America Acne Medicine Market Size by Type (2017-2022) & (US$ Million)
  • Table 30. North America Acne Medicine Market Size by Type (2023-2028) & (US$ Million)
  • Table 31. North America Acne Medicine Market Size by Application (2017-2022) & (US$ Million)
  • Table 32. North America Acne Medicine Market Size by Application (2023-2028) & (US$ Million)
  • Table 33. North America Acne Medicine Market Size by Country (2017-2022) & (US$ Million)
  • Table 34. North America Acne Medicine Market Size by Country (2023-2028) & (US$ Million)
  • Table 35. Europe Acne Medicine Market Size by Type (2017-2022) & (US$ Million)
  • Table 36. Europe Acne Medicine Market Size by Type (2023-2028) & (US$ Million)
  • Table 37. Europe Acne Medicine Market Size by Application (2017-2022) & (US$ Million)
  • Table 38. Europe Acne Medicine Market Size by Application (2023-2028) & (US$ Million)
  • Table 39. Europe Acne Medicine Market Size by Country (2017-2022) & (US$ Million)
  • Table 40. Europe Acne Medicine Market Size by Country (2023-2028) & (US$ Million)
  • Table 41. Asia-Pacific Acne Medicine Market Size by Type (2017-2022) & (US$ Million)
  • Table 42. Asia-Pacific Acne Medicine Market Size by Type (2023-2028) & (US$ Million)
  • Table 43. Asia-Pacific Acne Medicine Market Size by Application (2017-2022) & (US$ Million)
  • Table 44. Asia-Pacific Acne Medicine Market Size by Application (2023-2028) & (US$ Million)
  • Table 45. Asia-Pacific Acne Medicine Market Size by Region (2017-2022) & (US$ Million)
  • Table 46. Asia-Pacific Acne Medicine Market Size by Region (2023-2028) & (US$ Million)
  • Table 47. South America Acne Medicine Market Size by Type (2017-2022) & (US$ Million)
  • Table 48. South America Acne Medicine Market Size by Type (2023-2028) & (US$ Million)
  • Table 49. South America Acne Medicine Market Size by Application (2017-2022) & (US$ Million)
  • Table 50. South America Acne Medicine Market Size by Application (2023-2028) & (US$ Million)
  • Table 51. South America Acne Medicine Market Size by Country (2017-2022) & (US$ Million)
  • Table 52. South America Acne Medicine Market Size by Country (2023-2028) & (US$ Million)
  • Table 53. Middle East & Africa Acne Medicine Market Size by Type (2017-2022) & (US$ Million)
  • Table 54. Middle East & Africa Acne Medicine Market Size by Type (2023-2028) & (US$ Million)
  • Table 55. Middle East & Africa Acne Medicine Market Size by Application (2017-2022) & (US$ Million)
  • Table 56. Middle East & Africa Acne Medicine Market Size by Application (2023-2028) & (US$ Million)
  • Table 57. Middle East & Africa Acne Medicine Market Size by Country (2017-2022) & (US$ Million)
  • Table 58. Middle East & Africa Acne Medicine Market Size by Country (2023-2028) & (US$ Million)
  • Table 59. Galderma Company Details
  • Table 60. Galderma Business Overview
  • Table 61. Galderma Acne Medicine Product
  • Table 62. Galderma Revenue in Acne Medicine Business (2020-2022) (US$ Million)
  • Table 63. Galderma Recent Development
  • Table 64. Bausch Health Company Details
  • Table 65. Bausch Health Business Overview
  • Table 66. Bausch Health Acne Medicine Product
  • Table 67. Bausch Health Revenue in Acne Medicine Business (2020-2022) (US$ Million)
  • Table 68. Bausch Health Recent Development
  • Table 69. Teva Company Details
  • Table 70. Teva Business Overview
  • Table 71. Teva Acne Medicine Product
  • Table 72. Teva Revenue in Acne Medicine Business (2020-2022) (US$ Million)
  • Table 73. Teva Recent Development
  • Table 74. GlaxoSmithKline Company Details
  • Table 75. GlaxoSmithKline Business Overview
  • Table 76. GlaxoSmithKline Acne Medicine Product
  • Table 77. GlaxoSmithKline Revenue in Acne Medicine Business (2020-2022) (US$ Million)
  • Table 78. GlaxoSmithKline Recent Development
  • Table 79. Viatris (Mylan) Company Details
  • Table 80. Viatris (Mylan) Business Overview
  • Table 81. Viatris (Mylan) Revenue in Acne Medicine Business (2020-2022) (US$ Million)
  • Table 82. Viatris (Mylan) Recent Development
  • Table 83. Almirall Company Details
  • Table 84. Almirall Business Overview
  • Table 85. Almirall Acne Medicine Product
  • Table 86. Almirall Revenue in Acne Medicine Business (2020-2022) (US$ Million)
  • Table 87. Almirall Recent Development
  • Table 88. Sun Pharma Company Details
  • Table 89. Sun Pharma Business Overview
  • Table 90. Sun Pharma Revenue in Acne Medicine Business (2020-2022) (US$ Million)
  • Table 91. Sun Pharma Recent Development
  • Table 92. Mayne Pharma Company Details
  • Table 93. Mayne Pharma Business Overview
  • Table 94. Mayne Pharma Acne Medicine Product
  • Table 95. Mayne Pharma Revenue in Acne Medicine Business (2020-2022) (US$ Million)
  • Table 96. Mayne Pharma Recent Development
  • Table 97. Lion Company Details
  • Table 98. Lion Business Overview
  • Table 99. Lion Acne Medicine Product
  • Table 100. Lion Revenue in Acne Medicine Business (2020-2022) (US$ Million)
  • Table 101. HUAPONT Company Details
  • Table 102. HUAPONT Business Overview
  • Table 103. HUAPONT Acne Medicine Product
  • Table 104. HUAPONT Revenue in Acne Medicine Business (2020-2022) (US$ Million)
  • Table 105. Sine Pharma Company Details
  • Table 106. Sine Pharma Business Overview
  • Table 107. Sine Pharma Revenue in Acne Medicine Business (2020-2022) (US$ Million)
  • Table 108. Sine Pharma Recent Development
  • Table 109. Research Programs/Design for This Report
  • Table 110. Key Data Information from Secondary Sources
  • Table 111. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Acne Medicine Picture
  • Figure 2. Global Acne Medicine Market Share by Type: 2021
  • Figure 3. Global Acne Medicine Market Share by Type: 2028
  • Figure 4. OTC Features
  • Figure 5. Prescription Medicine Features
  • Figure 6. Global Acne Medicine Market Share by Application: 2021
  • Figure 7. Global Acne Medicine Market Share by Application: 2028
  • Figure 8. Topical Case Studies
  • Figure 9. Oral Case Studies
  • Figure 10. Acne Medicine Report Years Considered
  • Figure 11. Global Acne Medicine Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 12. Global Acne Medicine Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 13. Global Acne Medicine Market Share by Region: 2021
  • Figure 14. Global Acne Medicine Market Share by Region: 2028
  • Figure 15. Global Acne Medicine Market Share by Players in 2021
  • Figure 16. The Top 3 Players Market Share by Acne Medicine Revenue in 2021
  • Figure 17. The Top 5 Players Market Share by Acne Medicine Revenue in 2021
  • Figure 18. North America Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 19. North America Acne Medicine Market Share by Type (2017-2028)
  • Figure 20. North America Acne Medicine Market Share by Application (2017-2028)
  • Figure 21. North America Acne Medicine Market Share by Country (2017-2028)
  • Figure 22. United States Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Canada Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. Mexico Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 25. Europe Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 26. Europe Acne Medicine Market Share by Type (2017-2028)
  • Figure 27. Europe Acne Medicine Market Share by Application (2017-2028)
  • Figure 28. Europe Acne Medicine Market Share by Country (2017-2028)
  • Figure 29. Germany Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. France Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. U.K. Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Italy Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 33. Russia Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 34. Asia-Pacific Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 35. Asia-Pacific Acne Medicine Market Share by Type (2017-2028)
  • Figure 36. Asia-Pacific Acne Medicine Market Share by Application (2017-2028)
  • Figure 37. Asia-Pacific Acne Medicine Market Share by Region (2017-2028)
  • Figure 38. China Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Japan Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. South Korea Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 41. Southeast Asia Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 42. India Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 43. Australia Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 44. South America Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 45. South America Acne Medicine Market Share by Type (2017-2028)
  • Figure 46. South America Acne Medicine Market Share by Application (2017-2028)
  • Figure 47. South America Acne Medicine Market Share by Country (2017-2028)
  • Figure 48. Brazil Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Middle East & Africa Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 50. Middle East & Africa Acne Medicine Market Share by Type (2017-2028)
  • Figure 51. Middle East & Africa Acne Medicine Market Share by Application (2017-2028)
  • Figure 52. Middle East & Africa Acne Medicine Market Share by Country (2017-2028)
  • Figure 53. Middle East Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 54. Africa Acne Medicine Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 55. Viatris (Mylan) Acne Medicine Product
  • Figure 56. Sun Pharma Acne Medicine Product
  • Figure 57. Sine Pharma Acne Medicine Product
  • Figure 58. Bottom-up and Top-down Approaches for This Report
  • Figure 59. Data Triangulation
  • Figure 60. Key Executives Interviewed
目次

Market Analysis and Insights:

The global Acne Medicine market size is projected to reach US$ 4428 million by 2028, from US$ 3491 million in 2021, at a CAGR of 3.43% during 2022-2028.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acne Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acne Medicine market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acne Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acne Medicine market.

Scope and Market Size:

Acne Medicine market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acne Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.

By Company

  • Galderma
  • Bausch Health
  • Teva
  • GlaxoSmithKline
  • Viatris
  • Almirall
  • Sun Pharma
  • Mayne Pharma
  • Lion
  • HUAPONT
  • Sine Pharma

Segment by Type

  • OTC
  • Prescription Medicine

Segment by Application

  • Topical
  • Oral

By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Rest of South America
  • Middle East & Africa
    • Middle East
    • Africa

TABLE OF CONTENTS

1 REPORT OVERVIEW

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Acne Medicine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
    • 1.2.2 OTC
    • 1.2.3 Prescription Medicine
  • 1.3 Market by Application
    • 1.3.1 Global Acne Medicine Market Share by Application: 2017 VS 2021 VS 2028
    • 1.3.2 Topical
    • 1.3.3 Oral
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 GLOBAL GROWTH TRENDS

  • 2.1 Global Acne Medicine Market Perspective (2017-2028)
  • 2.2 Acne Medicine Growth Trends by Region
    • 2.2.1 Acne Medicine Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Acne Medicine Historic Market Size by Region (2017-2022)
    • 2.2.3 Acne Medicine Forecasted Market Size by Region (2023-2028)
  • 2.3 Acne Medicine Market Dynamics
    • 2.3.1 Acne Medicine Industry Trends
    • 2.3.2 Acne Medicine Market Drivers
    • 2.3.3 Acne Medicine Market Restraints
    • 2.3.4 Acne Medicine Market Growth Strategy

3 COMPETITION LANDSCAPE BY KEY PLAYERS

  • 3.1 Global Top Acne Medicine Players by Revenue
    • 3.1.1 Global Top Acne Medicine Players by Revenue (2020-2022)
    • 3.1.2 Global Acne Medicine Revenue Market Share by Players (2020-2022)
  • 3.2 Global Acne Medicine by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Acne Medicine Revenue
  • 3.4 Global Acne Medicine Market Concentration Ratio
    • 3.4.1 Global Acne Medicine Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 3 and Top 5 Companies by Acne Medicine Revenue in 2021
  • 3.5 Acne Medicine Key Players Head office and Area Served
  • 3.6 Key Players Acne Medicine Product Solution and Service
  • 3.7 Founded Date of Acne Medicine Players
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 ACNE MEDICINE BREAKDOWN DATA BY TYPE

  • 4.1 Global Acne Medicine Historic Market Size by Type (2017-2022)
  • 4.2 Global Acne Medicine Forecasted Market Size by Type (2023-2028)

5 ACNE MEDICINE BREAKDOWN DATA BY APPLICATION

  • 5.1 Global Acne Medicine Historic Market Size by Application (2017-2022)
  • 5.2 Global Acne Medicine Forecasted Market Size by Application (2023-2028)

6 NORTH AMERICA

  • 6.1 North America Acne Medicine Market Size (2017-2028)
  • 6.2 North America Acne Medicine Market Size by Type
    • 6.2.1 North America Acne Medicine Market Size by Type (2017-2022)
    • 6.2.2 North America Acne Medicine Market Size by Type (2023-2028)
    • 6.2.3 North America Acne Medicine Market Share by Type (2017-2028)
  • 6.3 North America Acne Medicine Market Size by Application
    • 6.3.1 North America Acne Medicine Market Size by Application (2017-2022)
    • 6.3.2 North America Acne Medicine Market Size by Application (2023-2028)
    • 6.3.3 North America Acne Medicine Market Share by Application (2017-2028)
  • 6.4 North America Acne Medicine Market Size by Country
    • 6.4.1 North America Acne Medicine Market Size by Country (2017-2022)
    • 6.4.2 North America Acne Medicine Market Share by Country (2023-2028)
    • 6.4.3 United States
    • 6.4.4 Canada
    • 6.4.5 Mexico

7 EUROPE

  • 7.1 Europe Acne Medicine Market Size (2017-2028)
  • 7.2 Europe Acne Medicine Market Size by Type
    • 7.2.1 Europe Acne Medicine Market Size by Type (2017-2022)
    • 7.2.2 Europe Acne Medicine Market Size by Type (2023-2028)
    • 7.2.3 Europe Acne Medicine Market Share by Type (2017-2028)
  • 7.3 Europe Acne Medicine Market Size by Application
    • 7.3.1 Europe Acne Medicine Market Size by Application (2017-2022)
    • 7.3.2 Europe Acne Medicine Market Size by Application (2023-2028)
    • 7.3.3 Europe Acne Medicine Market Share by Application (2017-2028)
  • 7.4 Europe Acne Medicine Market Size by Country
    • 7.4.1 Europe Acne Medicine Market Size by Country (2017-2022)
    • 7.4.2 Europe Acne Medicine Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia

8 ASIA-PACIFIC

  • 8.1 Asia-Pacific Acne Medicine Market Size (2017-2028)
  • 8.2 Asia-Pacific Acne Medicine Market Size by Type
    • 8.2.1 Asia-Pacific Acne Medicine Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Acne Medicine Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Acne Medicine Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Acne Medicine Market Size by Application
    • 8.3.1 Asia-Pacific Acne Medicine Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Acne Medicine Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Acne Medicine Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Acne Medicine Market Size by Region
    • 8.4.1 Asia-Pacific Acne Medicine Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Acne Medicine Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 SOUTH AMERICA

  • 9.1 South America Acne Medicine Market Size (2017-2028)
  • 9.2 South America Acne Medicine Market Size by Type
    • 9.2.1 South America Acne Medicine Market Size by Type (2017-2022)
    • 9.2.2 South America Acne Medicine Market Size by Type (2023-2028)
    • 9.2.3 South America Acne Medicine Market Share by Type (2017-2028)
  • 9.3 South America Acne Medicine Market Size by Application
    • 9.3.1 South America Acne Medicine Market Size by Application (2017-2022)
    • 9.3.2 South America Acne Medicine Market Size by Application (2023-2028)
    • 9.3.3 South America Acne Medicine Market Share by Application (2017-2028)
  • 9.4 South America Acne Medicine Market Size by Country
    • 9.4.1 South America Acne Medicine Market Size by Country (2017-2022)
    • 9.4.2 South America Acne Medicine Market Size by Country (2023-2028)
    • 9.4.3 Brazil

10 MIDDLE EAST & AFRICA

  • 10.1 Middle East & Africa Acne Medicine Market Size (2017-2028)
  • 10.2 Middle East & Africa Acne Medicine Market Size by Type
    • 10.2.1 Middle East & Africa Acne Medicine Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Acne Medicine Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Acne Medicine Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Acne Medicine Market Size by Application
    • 10.3.1 Middle East & Africa Acne Medicine Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Acne Medicine Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Acne Medicine Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Acne Medicine Market Size by Country
    • 10.4.1 Middle East & Africa Acne Medicine Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Acne Medicine Market Size by Country (2023-2028)
    • 10.4.3 Middle East
    • 10.4.4 Africa

11 KEY PLAYERS PROFILES

  • 11.1 Galderma
    • 11.1.1 Galderma Company Details
    • 11.1.2 Galderma Company Description and Business Overview
    • 11.1.3 Galderma Acne Medicine Introduction
    • 11.1.4 Galderma Revenue in Acne Medicine Business (2020-2022)
    • 11.1.5 Galderma Recent Development
  • 11.2 Bausch Health
    • 11.2.1 Bausch Health Company Details
    • 11.2.2 Bausch Health Company Description and Business Overview
    • 11.2.3 Bausch Health Acne Medicine Introduction
    • 11.2.4 Bausch Health Revenue in Acne Medicine Business (2020-2022)
    • 11.2.5 Bausch Health Recent Development
  • 11.3 Teva
    • 11.3.1 Teva Company Details
    • 11.3.2 Teva Company Description and Business Overview
    • 11.3.3 Teva Acne Medicine Introduction
    • 11.3.4 Teva Revenue in Acne Medicine Business (2020-2022)
    • 11.3.5 Teva Recent Development
  • 11.4 GlaxoSmithKline
    • 11.4.1 GlaxoSmithKline Company Details
    • 11.4.2 GlaxoSmithKline Company Description and Business Overview
    • 11.4.3 GlaxoSmithKline Acne Medicine Introduction
    • 11.4.4 GlaxoSmithKline Revenue in Acne Medicine Business (2020-2022)
    • 11.4.5 GlaxoSmithKline Recent Development
  • 11.5 Viatris (Mylan)
    • 11.5.1 Viatris (Mylan) Company Details
    • 11.5.2 Viatris (Mylan) Company Description and Business Overview
    • 11.5.3 Viatris (Mylan) Acne Medicine Introduction
    • 11.5.4 Viatris (Mylan) Revenue in Acne Medicine Business (2020-2022)
    • 11.5.5 Viatris (Mylan) Recent Development
  • 11.6 Almirall
    • 11.6.1 Almirall Company Details
    • 11.6.2 Almirall Company Description and Business Overview
    • 11.6.3 Almirall Acne Medicine Introduction
    • 11.6.4 Almirall Revenue in Acne Medicine Business (2020-2022)
    • 11.6.5 Almirall Recent Development
  • 11.7 Sun Pharma
    • 11.7.1 Sun Pharma Company Details
    • 11.7.2 Sun Pharma Company Description and Business Overview
    • 11.7.3 Sun Pharma Acne Medicine Introduction
    • 11.7.4 Sun Pharma Revenue in Acne Medicine Business (2020-2022)
    • 11.7.5 Sun Pharma Recent Development
  • 11.8 Mayne Pharma
    • 11.8.1 Mayne Pharma Company Details
    • 11.8.2 Mayne Pharma Company Description and Business Overview
    • 11.8.3 Mayne Pharma Acne Medicine Introduction
    • 11.8.4 Mayne Pharma Revenue in Acne Medicine Business (2020-2022)
    • 11.8.5 Mayne Pharma Recent Development
  • 11.9 Lion
    • 11.9.1 Lion Company Details
    • 11.9.2 Lion Company Description and Business Overview
    • 11.9.3 Lion Acne Medicine Introduction
    • 11.9.4 Lion Revenue in Acne Medicine Business (2020-2022)
  • 11.10 HUAPONT
    • 11.10.1 HUAPONT Company Details
    • 11.10.2 HUAPONT Company Description and Business Overview
    • 11.10.3 HUAPONT Acne Medicine Introduction
    • 11.10.4 HUAPONT Revenue in Acne Medicine Business (2020-2022)
  • 11.11 Sine Pharma
    • 11.11.1 Sine Pharma Company Details
    • 11.11.2 Sine Pharma Company Description and Business Overview
    • 11.11.3 Sine Pharma Acne Medicine Introduction
    • 11.11.4 Sine Pharma Revenue in Acne Medicine Business (2020-2022)
    • 11.11.5 Sine Pharma Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS

13 APPENDIX

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details 106